Pharos iBio Co., Ltd. (KOSDAQ:388870)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,700.00
-40.00 (-0.46%)
At close: Mar 9, 2026

Pharos iBio Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
112.63B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022300.00M243.00M426.32%
Dec 31, 202157.00M-130.68M-69.63%
Dec 31, 2020187.68M-233.43M-55.43%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
WITHUS PHARMACEUTICAL Co.,LTD. 102.11B
Samik Pharmaceutical Company LTD. 58.88B
HYUNDAI BIOLAND 129.68B
H.PIO 257.56B
PHARMARESEARCH BIO 178.19M
Sam-A Pharm. 76.66B
KOREA PHARMA 90.11B
Daehan Nupharm 201.59B
Revenue Rankings